Objective:

To evaluate the effects of polystyrene nanoplastics on gastrointestinal, metabolic, hepatic, and neurologic outcomes in a mouse model of Parkinson's disease.

Approach:

• Study Design: Mice were fed polystyrene nanoplastics every other day for three months following intestinal administration of A53T α-synuclein.

Key Findings:

• Nanoplastic exposure resulted in fewer mucus-producing cells and increased cell death in the gut lining.
• Gut bacteria composition changed, with a notable increase in Desulfovibrio, linked to hydrogen sulfide production.
• Biological pathways related to cell death and inflammation were more active in nanoplastic-exposed mice.
• Metabolomic profiling revealed over 200 significant changes in metabolites related to amino acids, fats, and drugs.
• Histopathologic evaluation showed liver inflammation in exposed mice, but no significant difference in cell death levels.
• Higher concentrations of A53T α-synuclein were detected in brain tissue of nanoplastic-exposed mice.

Interpretation:

Limitations:

• The sample size limits conclusions regarding sex-specific responses.
• Further investigations are needed with different types of nanoplastics and larger cohorts.

Conclusion:

Sources:

• npj Parkinson’s Disease